Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1271: Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stent in the Treatment of Octo- and Nonagenarian All Comer Patients with Coronary Artery Disease – Results from the Prospective Multicenter Cruz Senior Study

Presenter: Gregor Nelles

October 28, 2025

Presentation TCT 2025

TCT 1957: Improved Outcomes for In-Stent Restenosis PCI With Use of Sirolimus Eluting Ultra-thin Stent Platform

Presenter: Jared Romeo

October 28, 2025

Presentation TCT 2025

TCT 891: Safety and clinical performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry.

Presenter: Bimmer E. Claessen

October 28, 2025

Presentation TCT 2025

TCT 519: Sirolimus eluting balloon efficacy and safety. A prospective registry of large vs small vessels

Presenter: Marco Ferrone

October 28, 2025

Presentation TCT 2025

TCT 889: A Multicenter Observational Study in France Assessing Sirolimus-Eluting Biodegradable Polymer Stent for CAD Patients Undergoing PCI in Routine Clinical Practice

Presenter: Adnan Kastrati

October 28, 2025

Presentation TCT 2025

TCT 520: Revascularization in HBR Made Safer: Leveraging Sirolimus-DCB and SAPT

Presenter: Victor Alfonso Jimenez Diaz

October 28, 2025

Presentation TCT 2025

TCT 528: Sirolimus-Coated Balloon with Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 28, 2025

Presentation TCT 2025

TCT 529: Clinical Outcomes after Scoring-balloon and Sirolimus-eluting Balloon Strategy in Diffuse Small-vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Valery Ljubenov Gelev

October 28, 2025

Presentation TCT 2025

TCT 241: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

Presenter: Matthias Lutz

October 28, 2025

Presentation TCT 2025

TCT 467: Comparative Long-Term Outcomes Of Sirolimus vs Paclitaxel-Coated Balloons In STEMI: A Retrospective Analysis

Presenter: Bhagya Harindi Loku Waduge

October 27, 2025

Presentation TCT 2025

TCT 469: Comparative Outcomes of Sirolimus versus Paclitaxel-Coated Balloon Angioplasty in De Novo Coronary Lesions: Real-World Data

Presenter: Bhagya Harindi Loku Waduge

October 27, 2025

Presentation TCT 2025

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

Presenter: Lei Song

October 27, 2025

Presentation TCT 2025

TCT 483: SIroliMus-coated Balloon-based PCI versus DES-onLy PCI in patiEnts with DiabetES Mellitus: The SIMPLE-DM Individual Patient Data analysis

Presenter: Mauro Gitto

October 27, 2025

Presentation TCT 2025

TCT 517: Safety and efficacy of sirolimus-coated drug balloons for percutaneous coronary interventions in a real-world cohort: Results from the Selution-SIROOP registry

Presenter: Matthias Bossard

October 27, 2025

Presentation TCT 2025

TCT 671: From Transfer to Retention: In-Vivo OCT Insights into Crystalline Sirolimus Behavior After Drug-Coated Balloon Angioplasty in De Novo Lesions

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2025

Presentation TCT 2025

TCT 1080: Sirolimus-Coated Balloon Angioplasty for STEMI Lesions: Long-Term Outcomes from a Real-World Single-Centre Experience

Presenter: Bhagya Harindi Loku Waduge

October 27, 2025

Presentation TCT 2025

TCT 233: FANTOM II Study: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – Pooled Analysis From 3 Study Cohorts

Presenter: Matthias Lutz

October 26, 2025

Presentation TCT 2025

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

Presenter: Tuomas T. Rissanen

October 26, 2025

Presentation TCT 2025

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Presenter: Rym El Khoury

October 26, 2025

Presentation TCT 2025

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

Presenter: Ulf Teichgräber

October 26, 2025

Advertisement

TCT 1271: Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stent in the Treatment of Octo- and Nonagenarian All Comer Patients with Coronary Artery Disease – Results from the Prospective Multicenter Cruz Senior Study

TCT 1957: Improved Outcomes for In-Stent Restenosis PCI With Use of Sirolimus Eluting Ultra-thin Stent Platform

TCT 891: Safety and clinical performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry.

TCT 519: Sirolimus eluting balloon efficacy and safety. A prospective registry of large vs small vessels

TCT 889: A Multicenter Observational Study in France Assessing Sirolimus-Eluting Biodegradable Polymer Stent for CAD Patients Undergoing PCI in Routine Clinical Practice

TCT 520: Revascularization in HBR Made Safer: Leveraging Sirolimus-DCB and SAPT

TCT 528: Sirolimus-Coated Balloon with Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease

TCT 529: Clinical Outcomes after Scoring-balloon and Sirolimus-eluting Balloon Strategy in Diffuse Small-vessel Coronary Artery Disease (SCA-DEB Study)

TCT 241: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

TCT 467: Comparative Long-Term Outcomes Of Sirolimus vs Paclitaxel-Coated Balloons In STEMI: A Retrospective Analysis

TCT 469: Comparative Outcomes of Sirolimus versus Paclitaxel-Coated Balloon Angioplasty in De Novo Coronary Lesions: Real-World Data

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

TCT 483: SIroliMus-coated Balloon-based PCI versus DES-onLy PCI in patiEnts with DiabetES Mellitus: The SIMPLE-DM Individual Patient Data analysis

TCT 517: Safety and efficacy of sirolimus-coated drug balloons for percutaneous coronary interventions in a real-world cohort: Results from the Selution-SIROOP registry

TCT 671: From Transfer to Retention: In-Vivo OCT Insights into Crystalline Sirolimus Behavior After Drug-Coated Balloon Angioplasty in De Novo Lesions

TCT 1080: Sirolimus-Coated Balloon Angioplasty for STEMI Lesions: Long-Term Outcomes from a Real-World Single-Centre Experience

TCT 233: FANTOM II Study: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – Pooled Analysis From 3 Study Cohorts

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

TCT 904: Treatment of femoropopliteal disease with a serial, sirolimus-eluting, bioresorbable vascular scaffold system: Results of the First-in-Human EFEMORAL I clinical trial

Two-year Outcome of Sirolimus-coated Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: Evidence from the Randomized SIRONA Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content